No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Raymond James Maintains Pacira BioSciences(PCRX.US) With Hold Rating
Sector Update: Health Care Stocks Weaker Late Afternoon
TD Synnex, Walgreens, Savers Value Village And Other Big Stocks Moving Higher On Friday
Pacira Biosciences Shares Are Trading Higher After the Company Reported a Preliminary Year-over-year Increase in FY25 Revenue.
Express News | Pacira Biosciences: Prelim Q4 Exparel Net Product Sales of $147.7 Mln
Express News | Pacira Biosciences: Sees Double-Digit Compounded Annual Growth Rate in Product Revenue by 2030